Funding for this research was provided by:
Beijing Municipal Science and Technology Commission (D171100003217001, D171100003217001, D171100003217001, D171100003217001, D171100003217001)
Peking University Medical Science and Technology Innovation Cultivation Fund for youth (BMU2021PYB034)
Received: 1 December 2022
Accepted: 14 April 2023
First Online: 12 May 2023
: We confirm that all experiments were performed in accordance with the Declaration of Helsinki. The study was approved by the Ethics Committee of Peking University Third Hospital, Beijing, China (Approval No. IRB00006761-M2017127), and was registered in the Chinese Clinical Trial Registry (ChiCTR-ROC-17013790). Each patient provided written informed consent before participating in the study.
: Not applicable.
: The authors declare that they have no competing interests.